InMode (INMD) Revenue & Revenue Breakdown
InMode Revenue Highlights
Latest Revenue (Y)
$492.05M
Latest Revenue (Q)
$80.28M
InMode Revenue by Period
InMode Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | $492.05M | 8.32% |
2022-12-31 | $454.27M | 27.05% |
2021-12-31 | $357.56M | 73.49% |
2020-12-31 | $206.11M | 31.81% |
2019-12-31 | $156.36M | 56.11% |
2018-12-31 | $100.16M | 87.37% |
2017-12-31 | $53.46M | - |
InMode Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-03-31 | $80.28M | -36.68% |
2023-12-31 | $126.78M | 2.98% |
2023-09-30 | $123.11M | -9.53% |
2023-06-30 | $136.08M | 28.29% |
2023-03-31 | $106.07M | -20.59% |
2022-12-31 | $133.57M | 10.18% |
2022-09-30 | $121.23M | 6.77% |
2022-06-30 | $113.55M | 32.15% |
2022-03-31 | $85.92M | -22.27% |
2021-12-31 | $110.54M | 17.38% |
2021-09-30 | $94.18M | 7.85% |
2021-06-30 | $87.33M | 33.27% |
2021-03-31 | $65.52M | -12.85% |
2020-12-31 | $75.19M | 25.91% |
2020-09-30 | $59.71M | 94.10% |
2020-06-30 | $30.77M | -23.93% |
2020-03-31 | $40.44M | -13.96% |
2019-12-31 | $47.00M | 17.48% |
2019-09-30 | $40.01M | 3.13% |
2019-06-30 | $38.80M | 26.99% |
2019-03-31 | $30.55M | 6.15% |
2018-12-31 | $28.78M | 13.24% |
2018-09-30 | $25.42M | 1.47% |
2018-06-30 | $25.05M | 19.79% |
2018-03-31 | $20.91M | - |
InMode Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
ABT | Abbott Laboratories | $40.11B | $10.63B |
MDT | Medtronic | $32.36B | $7.92B |
SYK | Stryker | $20.50B | $5.49B |
EW | Edwards Lifesciences | $6.00B | $1.35B |
ALGN | Align | $3.86B | $977.87M |
DXCM | DexCom | $3.62B | $994.20M |
ZBH | Zimmer Biomet | $1.94B | $143.40M |
PODD | Insulet | $1.70B | $372.60M |
TNDM | Tandem Diabetes Care | $747.72M | $221.91M |
SWAV | ShockWave Medical | $730.23M | $218.81M |
INSP | Inspire Medical Systems | $624.80M | $203.19M |
NARI | Inari Medical | $493.63M | $153.39M |
INMD | InMode | $492.05M | $80.28M |
TMDX | TransMedics Group | $241.62M | $-12.24M |